Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer.

Twenty-five human bladder tumors were examined for loss of heterozygosity of markers on chromosomes 6p, 9q, 11p, 14q, and 17p. These studies show that all of the markers were reduced to homozygosity in at least some of the tumors. They also confirmed earlier studies by Fearon et al. [Nature (Lond.), 318: 377-380, 1985] that approximately 40% of bladder tumors were reduced to homozygosity for markers on chromosome 11p. However, the greatest frequency of allelic loss was seen for chromosomes 9q (67% of informative cases) and 17p (63% of informative cases) with both chromosomes being lost concordantly in 10 out of 20 informative tumors. Allelic loss of chromosome 9q has not been previously observed with other human cancers; however, deletions of 17p have been reported in breast, lung, and colorectal carcinomas. The data raise the interesting possibility that allelic losses of specific chromosomes might be a feature of cancer in a particular differentiated cell type whereas loss of other chromosomes harboring more generally acting tumor suppressor genes might be a common feature of human cancers.

[1]  K. Cummings,et al.  Diagnosis and staging of bladder cancer. , 1992, The Urologic clinics of North America.

[2]  J. Willey,et al.  Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Y. Nakamura,et al.  Allelotype of colorectal carcinomas. , 1989, Science.

[4]  D. Ledbetter,et al.  Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. , 1989, Science.

[5]  A. Forrest,et al.  ALLELE LOSS ON SHORT ARM OF CHROMOSOME 17 IN BREAST CANCERS , 1988, The Lancet.

[6]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[7]  Y. Nakamura,et al.  Isolation and mapping of a polymorphic DNA sequence (pYNZ22) on chromosome 17p [D17S30]. , 1988, Nucleic acids research.

[8]  H. Harris.  The Analysis of Malignancy by Cell Fusion: the Position in Updated Version Citing Articles E-mail Alerts , 2013 .

[9]  Y. Nakamura,et al.  Isolation and mapping of a polymorphic DNA sequence pMLJ14 on chromosome 14 [D14S13] , 1988, Nucleic Acids Res..

[10]  H. Brauch,et al.  Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma , 1988, Nature.

[11]  Y. Nakamura,et al.  Isolation and mapping of a polymorphic DNA sequence pMHZ10 on chromosome 9q (D9S11). , 1987, Nucleic acids research.

[12]  Y. Nakamura,et al.  Isolation and mapping of a polymorphic DNA sequence pEFD126.3 on chromosome 9q (D9S7). , 1987, Nucleic acids research.

[13]  B. Miles,et al.  Tumor behavior in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology. , 1987, Cancer research.

[14]  G. Klein,et al.  The approaching era of the tumor suppressor genes. , 1987, Science.

[15]  M Terada,et al.  Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Lidereau,et al.  Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia. , 1987, Science.

[17]  F. Debruyne,et al.  Chromosomal analysis of bladder cancer. III. Nonrandom alterations. , 1987, Cancer genetics and cytogenetics.

[18]  Iqbal Unnisa Ali,et al.  Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia , 1987 .

[19]  A. Geiser,et al.  Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression. , 1987, Science.

[20]  W. Cavenee,et al.  Loss of heterozygosity in human ductal breast tumors indicates a recessive mutation on chromosome 13. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[21]  E. Stanbridge,et al.  Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells. , 1986, The EMBO journal.

[22]  R. White,et al.  Construction of a map of the short arm of human chromosome 6. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Sandberg,et al.  A possible specific chromosome change in transitional cell carcinoma of the bladder. , 1986, Cancer genetics and cytogenetics.

[24]  H. Klinger.  Suppression of tumorigenicity in somatic cell hybrids. I. Suppression and reexpression of tumorigenicity in diploid human X D98AH2 hybrids and independent segregation of tumorigenicity from other cell phenotypes. , 1980, Cytogenetics and cell genetics.

[25]  A. Sandberg.  Chromosome changes in bladder cancer: clinical and other correlations. , 1986, Cancer genetics and cytogenetics.

[26]  P. Nichols,et al.  A simple and practical technic for detecting cancer cells in urine and urinary bladder washings by flow cytometry. , 1985, American journal of clinical pathology.

[27]  N. B. Atkin,et al.  Cytogenetic study of ten carcinomas of the bladder: involvement of chromosomes 1 and 11. , 1985, Cancer genetics and cytogenetics.

[28]  S. Daiger,et al.  Multiple, independent restriction site polymorphisms in human DNA detected with a cDNA probe to argininosuccinate synthetase (AS). , 1984, American journal of human genetics.

[29]  A. Sandberg,et al.  Nonrandom chromosomal changes in transitional cell carcinoma of the bladder. , 1984, Cancer research.

[30]  P. Stovin.  TNM-Atlas. Illustrated guide to the classification of malignant tumours , 1984 .

[31]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[32]  M. Barbacid,et al.  T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes , 1982, Nature.

[33]  P. Esposti,et al.  The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumours: a study of 100 untreated cases. , 1982, British journal of urology.

[34]  W. Rutter,et al.  Polymorphic DNA region adjacent to the 5' end of the human insulin gene. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[35]  O. Laerum,et al.  Clinical application of flow cytometry: a review. , 1981, Cytometry.

[36]  D. Skinner,et al.  Current state of classification and staging of bladder cancer. , 1977, Cancer research.

[37]  G. Moberger,et al.  Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. , 1965, Acta chirurgica Scandinavica.

[38]  J. Marmur.  A procedure for the isolation of deoxyribonucleic acid from micro-organisms , 1961 .

[39]  W. C. Spackman.  Correspondence , 1921, The Indian medical gazette.